Source: BioPortfolio

SeraCare: LGCs Clinical Diagnostics unit employing AccuPlex technology to develop quality control solutions in response to the coronavirus global health emergency

LGC's SeraCare Life Sciences a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuP...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael Sweatt's photo - General Manager of SeraCare

General Manager

Michael Sweatt

CEO Approval Rating

82/100

Read more